MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Molecular Medicine

• Publication date

  2015-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijmm.2015.2245PMID 26081980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers.

  2015cited by this paper
• Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery

  2015cited by this paper
• Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.

  2015cited by this paper
• Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus.

  2014cited by this paper
• Alterations of cell cycle control proteins SHP-1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells

  2014cited by this paper
• miR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro

  2014cited by this paper
• MicroRNAs in colorectal cancer: from diagnosis to targeted therapy.

  2014cited by this paper
• MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha

  2014cited by this paper
• MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14)

  2014cited by this paper
• Hypofractionated radiotherapy induces miR-34a expression and enhances apoptosis in human nasopharyngeal carcinoma cells.

  2014cited by this paper
• Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

  2014cited by this paper
• Integrated Analysis of Differential miRNA and mRNA Expression Profiles in Human Radioresistant and Radiosensitive Nasopharyngeal Carcinoma Cells

  2014cited by this paper
• Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma

  2014cited by this paper
• Influence of Recombinant Lentiviral Vector Encoding miR-15a/16-1 in Biological Features of Human Nasopharyngeal Carcinoma CNE-2Z Cells

  2014cited by this paper
• Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis.

  2013cited by this paper
• Current Treatment Options for Local Residual Nasopharyngeal Carcinoma

  2013cited by this paper
• Genome-Wide Analyses of Radioresistance-Associated miRNA Expression Profile in Nasopharyngeal Carcinoma Using Next Generation Deep Sequencing

  2013cited by this paper
• MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B.

  2013cited by this paper
• SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer

  2013cited by this paper
• Serum microRNAs: A new diagnostic method for colorectal cancer.

  2013cited by this paper
• Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells.

  2013cited by this paper
• Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences?

  2013cited by this paper
• MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy.

  2013cited by this paper
• MicroRNAs in human cancer.

  2013cited by this paper
• Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma

  2012cited by this paper
• MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN

  2012cited by this paper
• SHP-1 in cell-cycle regulation.

  2011cited by this paper
• Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma.

  2011cited by this paper
• Is nasopharyngeal cancer really a "Cantonese cancer"?

  2010cited by this paper
• [Effects of radiosensitivity and X-ray dose on miR-7 expression in nasopharyngeal carcinoma].

  2010cited by this paper
• rna interference and micro rna –oriented therapy in cancer: rationales, promises, and challenges

  2009cited by this paper
• Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized controlled trials.

  2008cited by this paper
• Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma

  2008cited by this paper
• Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.

  2008cited by this paper
• A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacy

  2008cited by this paper
• Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma.

  2007cited by this paper
• miR-21-mediated tumor growth

  2007cited by this paper
• Decreased expression level of SH2 domain‐containing protein tyrosine phosphatase‐1 (Shp1) is associated with progression of chronic myeloid leukaemia

  2007cited by this paper
• Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.

  2005cited by this paper
• Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

  2005cited by this paper
• Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

  2005cited by this paper
• Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.

  2001cited by this paper
• Downregulated Expression of SHP-1 in Burkitt Lymphomas and Germinal Center B Lymphocytes

  1997cited by this paper
• Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate promoter usage and exon skipping generate multiple transcripts.

  1995cited by this paper
• [A long survival case of small cell lung cancer synchronized with renal cancer].

  1991cited by this paper

• Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy

  2022cites this paper
• Long intergenic non-protein coding RNA 02570 promotes nasopharyngeal carcinoma progression by adsorbing microRNA miR-4649-3p thereby upregulating both sterol regulatory element binding protein 1, and fatty acid synthase

  2021influential citation
• A Pilot Study Comparing the Efficacy of Lactate Dehydrogenase Levels Versus Circulating Cell-Free microRNAs in Monitoring Responses to Checkpoint Inhibitor Immunotherapy in Metastatic Melanoma Patients

  2020cites this paper
• Is microRNA 1910-3p (miR-1910-3p) a really distinctive marker for psoriasis?

  2020cites this paper
• H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells.

  2019cites this paper
• miR‑214 reduces cisplatin resistance by targeting netrin‑1 in bladder cancer cells.

  2018cites this paper
• miR-185-3p regulates the invasion and metastasis of nasopharyngeal carcinoma by targeting WNT2B in vitro

  2017cites this paper
• MicroRNA-18 a high expressed in nasopharyngeal carcinoma facilitates tumor growth by targeting SKT 4

  2017cites this paper
• Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma

  2016influential citation